These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10766580)

  • 21. Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase.
    Peters GJ; van der Wilt CL; van Groeningen CJ
    Eur J Cancer; 1994; 30A(10):1408-11. PubMed ID: 7833092
    [No Abstract]   [Full Text] [Related]  

  • 22. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Kornmann M; Schwabe W; Sander S; Kron M; Sträter J; Polat S; Kettner E; Weiser HF; Baumann W; Schramm H; Häusler P; Ott K; Behnke D; Staib L; Beger HG; Link KH
    Clin Cancer Res; 2003 Sep; 9(11):4116-24. PubMed ID: 14519634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of mRNA expression levels determined with TaqMan and competitive template RT-PCR.
    Mauritz R; Schwabe W; Haeusler P; Noordhuis P; Smid K; McLeod HL; Behnke D; van Groeningen CJ; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1471-4. PubMed ID: 15571279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Where should the specimen be excised for the chemosensitivity of colorectal cancer to 5-fluorouracil?
    Ushigome T; Kawahara H; Kobayashi T; Kobayashi S; Kashiwagi H; Yanaga K
    Hepatogastroenterology; 2010; 57(102-103):1090-4. PubMed ID: 21410037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracil.
    Etienne MC; Pivot X; Formento JL; Bensadoun RJ; Formento P; Dassonville O; Francoual M; Poissonnet G; Fontana X; Schneider M; Demard F; Milano G
    Br J Cancer; 1999 Apr; 79(11-12):1864-9. PubMed ID: 10206306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of two fluorouracil administration regimens for colorectal cancer.
    Matsusaka S; Yamasaki H; Kitayama Y; Okada T; Maeda S
    Oncol Rep; 2003; 10(1):109-13. PubMed ID: 12469154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Factors of the therapeutic effectiveness of 5-fluorouracil].
    Manziuk LV; Donenko FV; Sitdikova SM; Moroz LV
    Vopr Onkol; 1996; 42(2):31-6. PubMed ID: 8815630
    [No Abstract]   [Full Text] [Related]  

  • 28. Correlations of clinicopathological factors with protein expression levels of thymidylate synthase, dihydropyrimidine dehydrogenase and orotate phosphoribosyltransferase in colorectal cancer.
    Sumi T; Katsumata K; Tsuchida A; Ishizaki T; Shimazu M; Aoki T
    Chemotherapy; 2010; 56(2):120-6. PubMed ID: 20407238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dihydropyrimidine dehydrogenase and resistance to 5-fluorouracil.
    Diasio RB
    Prog Exp Tumor Res; 1999; 36():115-23. PubMed ID: 10386069
    [No Abstract]   [Full Text] [Related]  

  • 30. High expression of thymidylate synthase leads to resistance to 5-fluorouracil in biliary tract carcinoma in vitro.
    Habara K; Ajiki T; Kamigaki T; Nakamura T; Kuroda Y
    Jpn J Cancer Res; 2001 Oct; 92(10):1127-32. PubMed ID: 11676864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thymidylate synthase expression and activity: relation to S-phase parameters and 5-fluorouracil sensitivity.
    Mirjolet JF; Barberi-Heyob M; Merlin JL; Marchal S; Etienne MC; Milano G; Bey P
    Br J Cancer; 1998 Jul; 78(1):62-8. PubMed ID: 9662252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thymidylate synthase and dihydropyrimidine dehydrogenase are upregulated in pancreatic and biliary tract cancers.
    Shimoda M; Sawada T; Kubota K
    Pathobiology; 2009; 76(4):193-8. PubMed ID: 19571608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dihydropyrimidine dehydrogenase: its role in 5-fluorouracil clinical toxicity and tumor resistance.
    Diasio RB; Johnson MR
    Clin Cancer Res; 1999 Oct; 5(10):2672-3. PubMed ID: 10537327
    [No Abstract]   [Full Text] [Related]  

  • 34. Dihydropyrimidine dehydrogenase activity and messenger RNA level may be related to the antitumor effect of 5-fluorouracil on human tumor xenografts in nude mice.
    Ishikawa Y; Kubota T; Otani Y; Watanabe M; Teramoto T; Kumai K; Kitajima M; Takechi T; Okabe H; Fukushima M
    Clin Cancer Res; 1999 Apr; 5(4):883-9. PubMed ID: 10213225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thymidylate synthase and drug resistance.
    Peters GJ; van der Wilt CL; van Triest B; Codacci-Pisanelli G; Johnston PG; van Groeningen CJ; Pinedo HM
    Eur J Cancer; 1995; 31A(7-8):1299-305. PubMed ID: 7577040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-time RT-PCR (TaqMan) of tumor mRNA to predict sensitivity of specimens to 5-fluorouracil.
    Kubota T
    Methods Mol Med; 2005; 111():257-65. PubMed ID: 15911984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A preliminary study on dihydropyrimidine dehydrogenase activity in breast cancer].
    Hamaji M; Miyazaki S; Nishida Y; Izukura M; Nishijima J; Oka Y; Seshimo I; Ohwari M
    Gan To Kagaku Ryoho; 2000 Oct; 27(11):1719-24. PubMed ID: 11057323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-Fluorouracil pharmacogenomics: still rocking after all these years?
    Scartozzi M; Maccaroni E; Giampieri R; Pistelli M; Bittoni A; Del Prete M; Berardi R; Cascinu S
    Pharmacogenomics; 2011 Feb; 12(2):251-65. PubMed ID: 21332317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
    Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T
    Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.